These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 33801148)
1. Pleiotropic Roles of ABC Transporters in Breast Cancer. He J; Fortunati E; Liu DX; Li Y Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801148 [TBL] [Abstract][Full Text] [Related]
2. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism. Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644 [TBL] [Abstract][Full Text] [Related]
3. Role of ATP-binding cassette transporters in cancer initiation and progression. Nobili S; Lapucci A; Landini I; Coronnello M; Roviello G; Mini E Semin Cancer Biol; 2020 Feb; 60():72-95. PubMed ID: 31412294 [TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]
5. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
6. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643 [TBL] [Abstract][Full Text] [Related]
7. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876 [TBL] [Abstract][Full Text] [Related]
8. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Kovalev AA; Tsvetaeva DA; Grudinskaja TV Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439 [TBL] [Abstract][Full Text] [Related]
9. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters. Shivhare S; Das A Mol Biol Rep; 2023 Jan; 50(1):215-225. PubMed ID: 36319789 [TBL] [Abstract][Full Text] [Related]
10. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
11. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Mohammad IS; He W; Yin L Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043 [TBL] [Abstract][Full Text] [Related]
12. ABC transporters in breast cancer: their roles in multidrug resistance and beyond. Modi A; Roy D; Sharma S; Vishnoi JR; Pareek P; Elhence P; Sharma P; Purohit P J Drug Target; 2022 Nov; 30(9):927-947. PubMed ID: 35758271 [TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? Adamska A; Falasca M World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Doyle L; Ross DD Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842 [TBL] [Abstract][Full Text] [Related]
15. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance. Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575 [TBL] [Abstract][Full Text] [Related]
16. lncRNAs: New players of cancer drug resistance via targeting ABC transporters. Ebrahimnezhad M; Asl SH; Rezaie M; Molavand M; Yousefi B; Majidinia M IUBMB Life; 2024 Nov; 76(11):883-921. PubMed ID: 39091106 [TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655 [TBL] [Abstract][Full Text] [Related]
18. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo. Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682 [TBL] [Abstract][Full Text] [Related]
19. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
20. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Lee CH Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]